Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.

Plasmodium falciparum causes the most severe form of malaria in humans. An important class of drugs in malaria treatment is the sulfone/sulfonamide group, of which sulfadoxine is the most commonly used. The target of sulfadoxine is the enzyme dihydropteroate synthase (DHPS), and sequencing of the DHPS gene has identified amino acid differences that may be involved in the mechanism of resistance to this drug. In this study we have sequenced the DHPS gene in 10 isolates from Thailand and identified a new allele of DHPS that has a previously unidentified amino acid difference. We have expressed eight alleles of P. falciparum PPPK-DHPS in Escherichia coli and purified the functional enzymes to homogeneity. Strikingly, the Ki for sulfadoxine varies by almost three orders of magnitude from 0.14 microM for the DHPS allele from sensitive isolates to 112 microM for an enzyme expressed in a highly resistant isolate. Comparison of the Ki of different sulfonamides and the sulfone dapsone has suggested that the amino acid differences in DHPS would confer cross-resistance to these compounds. These results show that the amino acid differences in the DHPS enzyme of sulfadoxine-resistant isolates of P. falciparum are central to the mechanism of resistance to sulfones and sulfonamides.

[1]  G. Coatney,et al.  The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. , 1961, Biochemical pharmacology.

[2]  R. Ferone.  Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei. , 1970, Journal of Biological Chemistry.

[3]  G. Brown,et al.  The biosynthesis of pteridines. , 1971, Advances in enzymology and related areas of molecular biology.

[4]  R. Ferone.  The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. , 1973, The Journal of protozoology.

[5]  W. Trager,et al.  Cultivation of malarial parasites , 1978, Nature.

[6]  R. D. Walter,et al.  7,8-Dihydropteroate-synthesizing enzyme from Plasmodium chabaudi. , 1980, Methods in enzymology.

[7]  W. Watkins,et al.  Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. , 1984, The American journal of tropical medicine and hygiene.

[8]  W. Watkins,et al.  Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. , 1985, Molecular and biochemical parasitology.

[9]  S. Lacks,et al.  Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme , 1987, Journal of bacteriology.

[10]  A. Cowman,et al.  Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Wellems,et al.  Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Krungkrai,et al.  De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. , 1989, Molecular and biochemical parasitology.

[13]  A. Cowman,et al.  Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum. , 1990, Biochemistry.

[14]  A. Cowman,et al.  Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Milhous,et al.  Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Kovacs,et al.  Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. , 1990, The Journal of clinical investigation.

[17]  A. Cowman,et al.  A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole , 1991, The Journal of cell biology.

[18]  Y. Zhang,et al.  Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs , 1991, Antimicrobial Agents and Chemotherapy.

[19]  W. Dallas,et al.  Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100 , 1992, Journal of bacteriology.

[20]  D. Stammers,et al.  The multifunctional folic acid synthesis fas gene of Pneumocystis carinii appears to encode dihydropteroate synthase and hydroxymethyldihydropterin pyrophosphokinase. , 1992, Gene.

[21]  J. E. Hyde,et al.  Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. , 1994, European journal of biochemistry.

[22]  W. Wernsdorfer,et al.  Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  T. Triglia,et al.  Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  O. Sköld,et al.  Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species , 1995, Journal of bacteriology.

[25]  J. E. Hyde,et al.  Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization , 1997, Molecular microbiology.